The global laparoscopic robot assisted systems market is experiencing significant growth driven by increasing adoption of robotic-assisted surgery, advancements in surgical precision, and shorter recovery times and patient preference. Laparoscopic robot assisted systems encompasses surgical robotic platforms, robotic arms/manipulators, robotic instruments, and robotic imaging and visualization systems. Robot-assisted surgical systems (RAS) are fundamentally changing surgery practice with unprecedented accuracy, dexterity, and visualization. The rise in popularity can be attributed to their ability to improve patient outcomes; they have been shown to lower blood loss in surgery by 85.3% compared to laparoscopy and 50.5% compared to open surgery.
Globally, the volume of robotic procedures will continue to expand, with more than 12 million da Vinci procedures performed worldwide as of May 2023 and a total of 2.68 million da Vinci procedures completed in 2024 (an 18% increase from the previous year). The integration of AI and machine learning will continue to increase RAS, with respects to enhanced preoperative planning, real-time decision support, and telesurgery, as illustrated by the intercontinental telesurgery, which established a world record in November of 2024, utilizing Microport’s Toumai system, by Morocco and This continuous innovation, and the significant benefits that derived from being a patient and surgeon, will solidify RAS’ role in the laparoscopic devices market.
You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00031677
Laparoscopic Robot Assisted Systems Market Segmentation Analysis
Key segments that contributed to the derivation of the laparoscopic robot assisted systems market analysis are product, application, and end user.
- By product, laparoscopic robot assisted systems market is segmented into surgical robotic platforms, robotic arms/manipulators, robotic instruments, and robotic imaging and visualization systems. The surgical robotic platforms segment dominated the market in 2024.
- In terms of application, the market is segmented into general surgery, bariatric surgery, gynecological surgery, colorectal surgery, others. The general surgery segment held the largest share of the market in 2024.
- By end user, the market is segmented into hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics segment held the largest share of the market in 2024.
Laparoscopic Robot Assisted Systems Market Drivers and Opportunities:
Increasing Adoption of Robotic Surgery Driving Laparoscopic Robot Assisted Systems Market
The growing acceptance of robotic surgery is a key factor driving the growth of the laparoscopic robotic-assisted systems market, as surgeons and health care providers are increasingly embracing robotic platforms for laparoscopic procedures given the improved control, precision, and dexterity they afford, resulting in improved patient outcomes. Laparoscopic robotic-assisted systems provide better range of motion and visualisation than laparoscopy, and are capable of performing complex procedures through small incisions, offering less trauma to the patient and faster recovery.
Robotic-assisted laparoscopic systems are being promoted in a growing number of surgical specialties including, but not limited to urology, gynecology, colorectal surgery, and general surgery. A number of studies have surfaced providing clinical evidence that supports and endorses the efficacy and safety of robotic-assisted laparoscopic techniques – thus encouraging hospitals and surgical centres to offer them. Furthermore, a new trend in reducing hospital stays and other postoperative complications is to entirely utilise and emphasize minimally invasive surgery which is a common approach among robotic systems. In all, robotic systems are becoming an increasingly favourite form of modern surgical care.
Penetration in Mid-tier Hospitals and Ambulatory Centers
The increasing penetration of laparoscopic robotic-assisted systems into mid-tier hospitals and ambulatory surgical centers offers an excellent opportunity to grow the market. Traditionally, high prices and space needed for robotic surgical platforms have limited the number of hospitals that were able to adopt robotic technology for surgical sessions to large, budget-crunched hospitals. However, as innovation continues to unfold, we are starting to see smaller and more affordable robotic systems be available allowing mid-tier healthcare organizations to incorporate robotic-assisted surgical technology into their operational framework. More healthcare providers are looking for ways to enhance surgical efficiency and attract more patients through efficiencies of care and minimally invasive procedures that are associated with laparoscopic robotic-assisted systems.
Similarly, the increasing competition amongst healthcare systems has encouraged mid-tier hospitals to invest in surgical technology and robotics support their surgical service and grow their patient base. The transition and shift of surgical care outside of hospitals and into outpatient settings has been increasingly prioritized as ambulatory surgical centers look for innovations such as robotics to increase processor safety, efficiency and outcomes for their patients. As robotics become accessible to a greater range of healthcare services and intraorganizational facilitators, we can expect to see significant growth in the laparoscopic robotic-assisted systems market.
Laparoscopic Robot Assisted Systems Market News and Key Development:
The laparoscopic robot assisted systems market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the laparoscopic robot assisted systems market are:
- Medtronic Plc announced that the Expand URO Investigational Device Exemption (IDE) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. The prospective, multi-center, single-arm IDE study included 137 patients who underwent urologic procedures using the Hugo robotic-assisted surgery (RAS) system. (Source: Medtronic Plc, Company Website, April 2025)
- Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced the completion of the first cases in the clinical trial for the OTTAVA Robotic Surgical System. The cases mark the first clinical experience with the OTTAVA System. Chief of Minimally Invasive and Elective General Surgery UT Health Houston and the lead investigator for the clinical study, performed Roux-en-Y gastric bypass surgery using the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center. (Source: Johnson & Johnson, Press Release, April 2025)
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031677
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: [email protected]
- Phone: +16467917070
